Home › Companies › ELEVANCE HEALTH INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ELEVANCE HEALTH INC.’s Form 8-K, filed May 15, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 15, 2024: 6 items on ELEVANCE HEALTH INC.’s Form 8-K, filed May 15, 2024: 3 elected · 2 approved · 1 not approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ELEVANCE HEALTH INC. in the interactive database Compare manager voting policies
These tallies are ELEVANCE HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Lewis Hay, III | 191,694,052 | 4,384,617 | 196,126 | -- | 12,814,049 | 98% | Elected | — |
| Elect Director: Antonio F. Neri | 189,550,610 | 6,514,535 | 209,650 | -- | 12,814,049 | 97% | Elected | — |
| Elect Director: Ramiro G. Peru | 183,447,281 | 12,625,588 | 201,926 | -- | 12,814,049 | 94% | Elected | — |
| 2. Advisory vote on the Company's executive compensation | 179,754,212 | 15,863,613 | 656,970 | -- | 12,814,049 | 92% | Approved | — |
| 3. Ratification of the appointment of Ernst & Young LLP | 186,378,524 | 22,541,679 | 168,641 | -- | -- | 89% | Approved | — |
| 4. Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations | 9,977,190 | 184,179,837 | 2,117,768 | -- | 12,814,049 | 5% | Not approved | — |
Source: ELEVANCE HEALTH INC., Form 8-K, filed with the SEC on May 15, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
1,197 asset managers disclosed a vote on at least one ELEVANCE HEALTH INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lewis Hay, III
ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Lewis Hay, III”): 191,694,052 for, 4,384,617 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2027 based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 209 asset managers below reported 74,811,208 for, 91,503 against, 44,757 abstained, 759 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,653,011 | 0 | 0 | 0 | For |
| Fidelity | 7,273,103 | 0 | 0 | 0 | For |
| BlackRock | 6,976,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,952,271 | 7,747 | 0 | 0 | For |
| Capital Group | 2,801,711 | 0 | 0 | 0 | For |
| State Street | 2,357,710 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,281,594 | 0 | 0 | 0 | For |
| TIAA | 2,120,207 | 0 | 0 | 0 | For |
| Dimensional | 1,564,809 | 0 | 0 | 0 | For |
| Invesco | 1,561,023 | 0 | 0 | 0 | For |
| Charles Schwab | 1,538,257 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,338,686 | 0 | 0 | 0 | For |
| MFS | 1,151,616 | 0 | 0 | 0 | For |
| JPMorgan | 1,031,096 | 0 | 0 | 0 | For |
| First Trust | 880,748 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 849,551 | 0 | 0 | 0 | For |
| John Hancock | 776,982 | 0 | 0 | 0 | For |
| Hartford | 753,212 | 0 | 0 | 0 | For |
| Brighthouse | 729,914 | 0 | 0 | 0 | For |
| Jackson National | 596,720 | 0 | 0 | 0 | For |
| GMO | 532,654 | 0 | 0 | 0 | For |
| Prudential/PGIM | 431,033 | 0 | 0 | 0 | For |
| Voya | 418,622 | 0 | 0 | 0 | For |
| Nuveen | 414,168 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 368,974 | 0 | 0 | 0 | For |
Showing the 25 largest of 209 asset managers. All 209 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Antonio F. Neri
ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Antonio F. Neri”): 189,550,610 for, 6,514,535 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2027 based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 209 asset managers below reported 72,709,702 for, 2,188,515 against, 49,252 abstained, 759 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,653,011 | 0 | 0 | 0 | For |
| Fidelity | 7,273,103 | 0 | 0 | 0 | For |
| BlackRock | 6,976,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,952,271 | 7,747 | 0 | 0 | For |
| Capital Group | 2,801,711 | 0 | 0 | 0 | For |
| State Street | 2,357,710 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 2,281,594 | 0 | 0 | 0 | For |
| TIAA | 2,120,207 | 0 | 0 | 0 | For |
| Dimensional | 1,564,809 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,561,023 | 0 | 0 | Against |
| Charles Schwab | 1,538,257 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,338,686 | 0 | 0 | 0 | For |
| MFS | 1,151,616 | 0 | 0 | 0 | For |
| JPMorgan | 1,031,096 | 0 | 0 | 0 | For |
| First Trust | 880,748 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 849,551 | 0 | 0 | 0 | For |
| John Hancock | 771,640 | 5,342 | 0 | 0 | For |
| Hartford | 753,099 | 113 | 0 | 0 | For |
| Brighthouse | 257,572 | 472,342 | 0 | 0 | Mixed |
| Jackson National | 596,720 | 0 | 0 | 0 | For |
| GMO | 532,654 | 0 | 0 | 0 | For |
| Prudential/PGIM | 431,033 | 0 | 0 | 0 | For |
| Voya | 418,622 | 0 | 0 | 0 | For |
| Nuveen | 414,168 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 368,974 | 0 | 0 | 0 | For |
Showing the 25 largest of 209 asset managers. All 209 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Ramiro G. Peru
ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Ramiro G. Peru”): 183,447,281 for, 12,625,588 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2027 based on the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 209 asset managers below reported 74,493,321 for, 409,390 against, 44,758 abstained, 759 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,653,011 | 0 | 0 | 0 | For |
| Fidelity | 7,273,103 | 0 | 0 | 0 | For |
| BlackRock | 6,976,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,952,271 | 7,747 | 0 | 0 | For |
| Capital Group | 2,801,711 | 0 | 0 | 0 | For |
| State Street | 2,357,660 | 50 | 0 | 0 | For |
| Columbia Threadneedle | 2,281,594 | 0 | 0 | 0 | For |
| TIAA | 2,120,207 | 0 | 0 | 0 | For |
| Dimensional | 1,564,809 | 0 | 0 | 0 | For |
| Invesco | 1,561,023 | 0 | 0 | 0 | For |
| Charles Schwab | 1,538,257 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,338,686 | 0 | 0 | 0 | For |
| MFS | 1,151,616 | 0 | 0 | 0 | For |
| JPMorgan | 1,031,096 | 0 | 0 | 0 | For |
| First Trust | 880,748 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 849,551 | 0 | 0 | 0 | For |
| John Hancock | 776,982 | 0 | 0 | 0 | For |
| Hartford | 753,212 | 0 | 0 | 0 | For |
| Brighthouse | 729,914 | 0 | 0 | 0 | For |
| Jackson National | 596,720 | 0 | 0 | 0 | For |
| GMO | 532,654 | 0 | 0 | 0 | For |
| Prudential/PGIM | 431,033 | 0 | 0 | 0 | For |
| Voya | 418,622 | 0 | 0 | 0 | For |
| Nuveen | 414,168 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 368,974 | 0 | 0 | 0 | For |
Showing the 25 largest of 209 asset managers. All 209 are in the interactive database (link above).
Combines 36 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: Advisory vote to approve the compensation of our named executive officers.
ELEVANCE HEALTH INC.’s own tally for this item (“2. Advisory vote on the Company's executive compensation”): 179,754,212 for, 15,863,613 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved based upon the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Section 14a Executive Compensation” (15 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,653,011 | 0 | 0 | 0 | For |
| Fidelity | 7,273,103 | 0 | 0 | 0 | For |
| BlackRock | 6,976,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,952,271 | 7,747 | 0 | 0 | For |
| Capital Group | 2,801,711 | 0 | 0 | 0 | For |
| Artisan | 2,431,781 | 0 | 0 | 0 | For |
| State Street | 2,357,660 | 50 | 0 | 0 | For |
| Columbia Threadneedle | 2,281,594 | 0 | 0 | 0 | For |
| TIAA | 2,120,207 | 0 | 0 | 0 | For |
| Dimensional | 1,564,809 | 0 | 0 | 0 | For |
| Invesco | 1,561,023 | 0 | 0 | 0 | For |
| Charles Schwab | 1,538,257 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,338,686 | 0 | 0 | 0 | For |
| MFS | 1,151,616 | 0 | 0 | 0 | For |
| JPMorgan | 1,031,096 | 0 | 0 | 0 | For |
| First Trust | 880,748 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 849,551 | 0 | 0 | 0 | For |
| John Hancock | 771,640 | 5,342 | 0 | 0 | For |
| Hartford | 753,212 | 0 | 0 | 0 | For |
| Brighthouse | 729,914 | 0 | 0 | 0 | For |
| Jackson National | 596,720 | 0 | 0 | 0 | For |
| GMO | 532,654 | 0 | 0 | 0 | For |
| Prudential/PGIM | 431,033 | 0 | 0 | 0 | For |
| Voya | 418,622 | 0 | 0 | 0 | For |
| Nuveen | 414,168 | 0 | 0 | 0 | For |
Fund voting reports, all 205 managers: 76,769,545 for, 419,589 against, 47,786 abstained, 759 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 11,581,428 | 22,006 | 0 | 0 | For |
| BlackRock | 9,478,238 | 1,774 | 0 | 0 | For |
| State Street | 6,398,691 | 83,828 | 0 | 0 | For |
| New York Life | 5,000,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,659,264 | 0 | 0 | 0 | For |
| Wellington | 4,331,273 | 0 | 0 | 0 | For |
| Fidelity | 3,829,926 | 0 | 0 | 0 | For |
| Capital Group | 3,569,177 | 100 | 0 | 0 | For |
| Nuveen | 2,842,185 | 1,150 | 0 | 0 | For |
| AllianceBernstein | 2,526,332 | 0 | 0 | 0 | For |
| Sanders Capital, LLC | 2,515,637 | 0 | 0 | 0 | For |
| Man Group plc | 2,382,800 | 0 | 0 | 0 | For |
| Northern Trust | 2,182,797 | 21,034 | 0 | 0 | For |
| National Pension Service | 1,901,531 | 0 | 0 | 0 | For |
| Brave Warrior Advisors, LLC | 1,760,180 | 0 | 0 | 0 | For |
| Invesco | 1,729,289 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,666,575 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 1,615,492 | 0 | 0 | 0 | For |
| John Hancock | 1,597,973 | 0 | 0 | 0 | For |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1,583,760 | 0 | 0 | 0 | For |
| Charles Schwab | 1,553,620 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 1,406,317 | 620 | 0 | 0 | For |
| JPMorgan | 1,366,768 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 1,352,177 | 0 | 0 | Against |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 1,333,699 | 0 | 0 | Against |
Institutional-manager reports, all 999 managers: 123,347,990 for, 11,422,192 against, 386,688 abstained, 24,326 not voted, 18,352 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
89% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2024.
ELEVANCE HEALTH INC.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP”): 186,378,524 for, 22,541,679 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024 was ratified based upon the following votes:”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of ELEVANCE HEALTH INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (4 managers, 6,405 for).
The 210 asset managers below reported 72,837,063 for, 2,113,084 against, 44,755 abstained, 759 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,515,117 | 1,137,894 | 0 | 0 | Mixed |
| Fidelity | 7,273,103 | 0 | 0 | 0 | For |
| BlackRock | 6,976,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,960,018 | 0 | 0 | 0 | For |
| Capital Group | 2,801,711 | 0 | 0 | 0 | For |
| State Street | 2,357,660 | 50 | 0 | 0 | For |
| Columbia Threadneedle | 2,281,594 | 0 | 0 | 0 | For |
| TIAA | 2,120,207 | 0 | 0 | 0 | For |
| Dimensional | 1,564,809 | 0 | 0 | 0 | For |
| Invesco | 1,561,023 | 0 | 0 | 0 | For |
| Charles Schwab | 1,538,257 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,338,686 | 0 | 0 | 0 | For |
| MFS | 1,151,616 | 0 | 0 | 0 | For |
| JPMorgan | 1,031,096 | 0 | 0 | 0 | For |
| First Trust | 880,748 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 849,551 | 0 | 0 | 0 | For |
| John Hancock | 776,982 | 0 | 0 | 0 | For |
| Hartford | 753,099 | 113 | 0 | 0 | For |
| Brighthouse | 728,604 | 1,310 | 0 | 0 | For |
| Jackson National | 596,720 | 0 | 0 | 0 | For |
| GMO | 532,654 | 0 | 0 | 0 | For |
| Prudential/PGIM | 431,033 | 0 | 0 | 0 | For |
| Voya | 418,622 | 0 | 0 | 0 | For |
| Nuveen | 414,168 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 368,974 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
5% Not approved · of votes cast
Description as filed by funds: Shareholder proposal to adopt a policy to require certain third-party organizations to annually report political activity expenditures prior to Elevance Health donating to the organizations.
ELEVANCE HEALTH INC.’s own tally for this item (“4. Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations”): 9,977,190 for, 184,179,837 against — failed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “The shareholder proposal requesting annual political activity reporting from third parties prior to the Company donating to the organization was not approved based upon the following votes:”
Support: 5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 204 asset managers below reported 121,323 for, 67,172,903 against, 282,916 abstained, 759 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 20,653,011 | 0 | 0 | Against |
| Fidelity | 0 | 7,273,103 | 0 | 0 | Against |
| T. Rowe Price | 0 | 5,960,018 | 0 | 0 | Against |
| Capital Group | 0 | 2,801,711 | 0 | 0 | Against |
| State Street | 0 | 2,357,710 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 2,281,594 | 0 | 0 | Against |
| TIAA | 0 | 2,120,207 | 0 | 0 | Against |
| Dimensional | 0 | 1,564,809 | 0 | 0 | Against |
| Invesco | 0 | 1,561,023 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,538,257 | 0 | 0 | Against |
| FIRST EAGLE FUNDS | 0 | 1,338,686 | 0 | 0 | Against |
| MFS | 0 | 1,151,616 | 0 | 0 | Against |
| JPMorgan | 0 | 1,031,096 | 0 | 0 | Against |
| First Trust | 0 | 880,748 | 0 | 0 | Against |
| FRANKLIN MUTUAL SERIES FUNDS | 0 | 849,551 | 0 | 0 | Against |
| John Hancock | 5,342 | 771,640 | 0 | 0 | Against |
| Hartford | 0 | 753,212 | 0 | 0 | Against |
| Brighthouse | 0 | 726,264 | 0 | 0 | Against |
| Jackson National | 0 | 596,720 | 0 | 0 | Against |
| GMO | 0 | 532,654 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 431,033 | 0 | 0 | Against |
| Voya | 0 | 418,622 | 0 | 0 | Against |
| Nuveen | 0 | 414,168 | 0 | 0 | Against |
| AllianceBernstein | 0 | 367,371 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 0 | 365,876 | 0 | 0 | Against |
Showing the 25 largest of 204 asset managers. All 204 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 14, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 232,544,717 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.88% |
| 2 | Fidelity | 3.13% |
| 3 | BlackRock | 3.00% |
| 4 | T. Rowe Price | 2.56% |
| 5 | Capital Group | 1.20% |
| 6 | Artisan | 1.05% |
| 7 | State Street | 1.01% |
| 8 | Columbia Threadneedle | 0.98% |
| 9 | TIAA | 0.91% |
| 10 | Dimensional | 0.67% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 4.99% |
| 2 | BlackRock | 4.08% |
| 3 | State Street | 2.79% |
| 4 | New York Life | 2.15% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.00% |
| 6 | Wellington | 1.86% |
| 7 | Fidelity | 1.65% |
| 8 | Capital Group | 1.53% |
| 9 | Nuveen | 1.22% |
| 10 | AllianceBernstein | 1.09% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 22,998,645 | 9.89% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 20,533,269 | 8.83% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 11,720,260 | 5.04% | Form 13F, quarter ended March 31, 2024 |
| State Street | 10,479,761 | 4.51% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 4,694,885 | 2.02% | Form 13F, quarter ended March 31, 2024 |
| Wellington Management | 4,499,629 | 1.93% | Form 13F, quarter ended March 31, 2024 |
| Capital International | 3,498,511 | 1.50% | Form 13F, quarter ended March 31, 2024 |
| Nuveen | 2,695,396 | 1.16% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 2,683,650 | 1.15% | Form 13F, quarter ended March 31, 2024 |
| Norges Bank | 2,495,994 | 1.07% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 232,544,717 shares outstanding, as reported by ELEVANCE HEALTH INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ELEVANCE HEALTH INC.'s shareholder meeting held May 15, 2024, in the 2023-2024 proxy season, 1,197 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 8,524 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve the compensation of our named executive officers. — ELEVANCE HEALTH INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ELEVANCE HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELEVANCE HEALTH INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ELEVANCE HEALTH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “ELEVANCE HEALTH (ELV) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/elevance-health-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.